
COVID-19ã¯ãã©ãŒããããªãã¯ã®ã¯ã¯ãã³è©Šéšããéããã®ãïŒãŠã€ã«ã¹ã®èµ·æºãç±³åœã®çç©å µåšç ç©¶æã§ããããšã瀺ã蚌æ
ã¡ãªãŒã©ã³ãå·ãã©ãŒããããªãã¯ããæŠæŒ¢ãã€ã³ãã«ãšã³ã¶ã®å®éã®çºçæºã¯ïŒ
ã©ãªãŒã»ãããã
ã°ããŒãã«ãªãµãŒã
Wed, 11 Mar 2020 17:56 UTC
å èšäºã¯ãã¡ãã
èæ¯ã«ã€ããŠã¯ããã®å
è¡èšäºãèªãã§ããã ããšåèã«ãªããšæããŸãã
äžåœã®ã³ãããŠã€ã«ã¹ãè¡æçãªææ°æ å ±ããŠã€ã«ã¹ã¯ç±³åœã§çºçããã®ãïŒ
äžèšã®èšäºãèªãã§ããã ããã°åããããã«ãæ¥æ¬ãšå°æ¹Ÿã®ç«åŠè
ãšè¬åŠè
ã¯ãæ°åã³ãããŠã€ã«ã¹ã¯ç±³åœã§çºçããå¯èœæ§ããããšå€æããã
ãªããªããç±³åœã¯5çš®é¡ãã¹ãŠã®åãæã€å¯äžã®åœã§ãããä»ã®ãã¹ãŠã®åã¯ããããæŽŸçããã«éããªãããã§ãããäžåœã®æŠæŒ¢ã«ã¯5ã€ã®åã®ãã¡1ã€ãããªãããããã®ãŠã€ã«ã¹ã¯ãæãã®ãããªãã®ã§ãããèªäœã§ã¯ååšã§ããããæšãããçããŠãããã®ã§ãªããã°ãªããªãã
å°æ¹Ÿã®å»åž«ã¯ã2019幎8æã«ç±³åœã§èºçãªã©ãçžæ¬¡ããç±³åœäººã¯é»åã¿ãã³ã®ããã€ãããåå ã ãšããããç§åŠè ã«ãããšãçç¶ãç¶æ ã¯é»åã¿ãã³ã§ã¯èª¬æã§ããªããšææããã圌ã¯ãç±³åœåœå±ã«ããããã®æ»äº¡ã¯ã³ãããŠã€ã«ã¹ã«ãããã®ã§ããå¯èœæ§ãé«ãããšãæçŽã§äŒãããšããã圌ã¯ã圌ã®èŠåã¯ç¡èŠããããšäž»åŒµããŠããã
ãã®çŽåãCDCã¯ã¡ãªãŒã©ã³ãå·ãã©ãŒããããªãã¯ã«ããç±³è»ã®äž»èŠãã€ãªç ç©¶æãç åäœã®æŒæŽ©ã«å¯Ÿããå®å šè£ 眮ããªãããšãçç±ã«å®å šã«ééããè»ã«ã忢åœä»€ããåºãããé»åã¿ãã³ãæµè¡ããã®ã¯ãã®çŽåŸã§ããã

ãŸãã2019幎9æã«ãã¯ã€ã§ãäžåœã«è¡ã£ãããšã®ãªãæ¥æ¬äººãææããŸãããããããã®ææã¯æŠæŒ¢ã§çºçãããã£ãšåã«ç±³åœå ã§çºçããŠããããã©ãŒããããªãã¯ãããã¯ããŠã³ããçŽåŸã§ããã
ãã®åŸãäžåœã®ãœãŒã·ã£ã«ã¡ãã£ã¢ã«ãäžèšã®ããšãèªèãã€ã€ãããããªã詳现ãæç€ºããå¥ã®èšäºãç»å ŽããŸãããããã¯ãäžçè»äºç«¶æå€§äŒïŒ2019幎10æ18æ¥ïœ27æ¥ïŒã®ããã«æŠæŒ¢ã蚪ãã5人ã®ãå€åœäººãéžæããã®ä»ã®è·å¡ããæªç¢ºå®ã®ææçã®ããã«æŠæŒ¢ã§å ¥é¢ãããšäžéšã§è¿°ã¹ãŠããã
èšäºã§ã¯ãæŠæŒ¢çãŠã€ã«ã¹ãç±³åœããã ãæ¥ãå¯èœæ§ãããããšãããæç¢ºã«èª¬æããŠããã"æ "ãšåŒã°ãããã®ã§ã"çš® "ããªããããæåã«äœãããããšã¯ããåŸãªãã£ãããã ããã®ãŠã€ã«ã¹ã¯ãæããšåŒã°ãããã®ã§ããçš®ãããªããããæåã«äœãããããšã¯ãªãã£ãã®ã ããã®ãæãã¯ããªãªãžãã«ã®ãå¹¹ãããã¹ãã³ãªãããæ°ããåçš®ã§ãªããã°ãªããããã®å¹¹ã¯ç±³åœã«ããååšããªã(1)ã
ã³ãããŠã€ã«ã¹ãæå³çã«äžåœã«æã¡èŸŒãŸãããšããæ¶æž¬ãäžéãè³ãããŠããããäžåœã®èšäºã«ããã°ããã£ãšéªæªãªä»£æ¿æ¡ãããåŸããšã®ããšã§ããã
ãããã¯ãŒã«ãã»ããªã¿ãªãŒã²ãŒã ïŒ10æ18æ¥ã27æ¥ïŒã®ç±³åœããŒã ã®ã¡ã³ããŒããã©ãŒãã»ãããªãã¯ã§å¶ç¶ã«çºçãããŠã€ã«ã¹ã«ææããå ŽåãåææœäŒæéãé·ããããçç¶ã¯è»œåŸ®ã§ãã£ãå¯èœæ§ãããããããã®äººã ã¯æ»åšäžã«æŠæŒ¢åžãç°¡åã«ã芳å ãããŠãåå°ã§æ°å人ã®å°å äœæ°ã«ææãããå¯èœæ§ããããå€ãã®äœæ°ã¯åŸã«æ°Žç£åžå Žã«è¡ãããããããŠã€ã«ã¹ã¯å€§ç«ãšãªã£ãŠæ¡æ£ããïŒäºå®ãããªã£ãïŒã®ã ããã§ããã
ã³ã¡ã³ãããã§ãããããããäžåãªèŠçŽ ãããå¯èœæ§ãæ®ãããŠããŸããç±³è»ã¯æ¥åžžçã«ç¥ã®ã¿ãç¥ãã¯ã¯ãã³ãæ¥çš®ããŠãããäžã«ã¯éºäŒåçµã¿æããŠã€ã«ã¹ãå«ãé«åºŠã«å®éšçãªãæå 端ãã®è¡åä¿®æ£ã¯ã¯ãã³ã®æåéãã®ã¢ã«ã¢ããã«ãªã£ãŠãããã®ãããã
ãã©ãŒãã»ãããªãã¯ã§è¡ãããéžæãããéšéã®å®éšã®äžã€ããæå³ããããã®ãšã¯éã®çµæïŒéšéãããåœä»€ã«åŸé ã«ãããã¯ãã®ã¯ã¯ãã³ã泚å°ããïŒãåºãããšããæå³ã§ã倱æããããšãããããããžã§ã¯ã管çè ã¯ããããå€ã«æŒãããã©ããªããåãã£ãŠãããã¯ã«ãªããåºå°ãäžæçã«å°éããŠéšéãéé¢ããã®ã§ããã
ãããã圌ãã®ç¥ããªããã¡ã«æ€ç«ã¯ããŸããããããŠã€ã«ã¹ã¯ç±³è»ã®éã§åºããããããŠäžåœã®æŠæŒ¢ïŒä»ã®å€ãã®å ŽæïŒã«ãå°éããŠããŸã£ããäžåœæ¿åºã¯æŠæŒ¢ã®ãããã¹ãããã«æ°ã¥ããŠåããŠãŠã€ã«ã¹ãç¹å®ããç±³åœã®çç©å µåšå°éå®¶ã«ãéºäŒåçµã¿æããŠã€ã«ã¹ããéæŸããã«ãªã£ãŠäººã ãå¶åŸ¡äžèœã«ããŠãããšããæªå€¢ãèŠåããã®ã§ãã...ã
ãããããšãäŒèª¬ã®ãæ£è ãŒãããèŠã€ããããšãçŸå®çã«äžå¯èœã§ããããšã説æã§ããããã®å Žåãæ£è ãŒãã¯ããããããã¯ããªã®ã§ãèŠã€ãã£ãŠããªãã
次ã«ãã¯ã·ã³ãã³ã®ãžã§ãŒãžã¿ãŠã³å€§åŠã®ææçå°éå®¶ã§ãããããšã«ã»ã«ãŒã·ãŒæ°ã¯ããµã€ãšã³ã¹èªã®èšäºã§ãæåã®äººãžã®ææã¯2019幎11æã«çºçããããšã確èªãããŠããïŒæŠæŒ¢ã§ã¯ãªãïŒããŠã€ã«ã¹ãå¥ã®å Žæã§çºçãããã®åŸæµ·é®®åžå Žã«åºãã£ãããšã瀺åããŠãããšè¿°ã¹ãŠããã"ããã°ã«ãŒãã¯ãçºçã®èµ·æºãæ©ãã2019幎9æ18æ¥ãšããŠãã"(2)(3)
æŠæŒ¢ã®æµ·é®®åžå Žã¯ãäžççã«åºããæ°åãŠã€ã«ã¹ã®çºçæºã§ã¯ãªãå¯èœæ§ãããã
æãæ©ãçäŸã®èšè¿°ãããã¢ãŠããã¬ã€ã¯ã®å§ãŸãã¯å¥ã®å Žæã§ããããšã瀺åãããã
èšäºã«ã¯ããããã
ãæ°åãŠã€ã«ã¹ã®ç¢ºå®çäŸãå¿é
ãªã»ã©ã®ã¹ããŒãã§äžçäžã«æ¥å¢ããŠããããããããŸã§ã®ãšãããäžåœæŠæŒ¢ã®æµ·ç£ç©åžå Žãçºçæºã§ã¯ãªãããšæ³šç®ãããŠãããããããéææ¥ã«The Lancetã«çºè¡šãããæåã®èšåºäŸã®èšè¿°ã¯ããã®ä»®èª¬ã«çåãæããããŠãã"(4)(5)
è€æ°ã®æ©é¢ãããªãäžåœã®ç ç©¶è ã°ã«ãŒãã«ãã£ãŠæžããããã®è«æã¯ã2019æ°åã³ãããŠã€ã«ã¹ïŒ2019-nCoVïŒãšåŒã°ãããŠã€ã«ã¹ãžã®ææã確èªãããæåã®å ¥é¢æ£è 41人ã«ã€ããŠã®è©³çްã瀺ããŠããŸãã
æãæ©ãã±ãŒã¹ã§ãæ£è ã¯2019幎12æ1æ¥ã«çºç ããæ°Žç£åžå Žãšã®é¢é£ã¯å ±åãããŠããªãã£ããšèè ãã¯å ±åããŠããŸãã"æåã®æ£è ãšãã以éã®çäŸãšã®éã«ç«åŠçãªé¢é£æ§ã¯èªããããªãã£ã "ãšåœŒãã¯è¿°ã¹ãŠããŸãããŸãã圌ãã®ããŒã¿ã«ãããšãåèš41äŸã®ãã¡13äŸã¯ãåžå Žãšã®é¢é£æ§ããªãããšã倿ããŸããããããšã«ã»ã«ãŒã·ãŒæ°ã¯ãã13äŸãšããã®ã¯å€§ããªæ°åã§ãäœã®é¢é£ããªãããšè¿°ã¹ãŠããã
ã³ã¡ã³ããã®éããããã¯ã©ããããæ¥ããã®ã§ãªããã°ãªããŸããã
äžåœä¿å¥åœå±ãšäžçä¿å¥æ©é¢ã®ä»¥åã®å ±åã§ã¯ãæåã®æ£è ã¯2019幎12æ8æ¥ã«çç¶ãçºçãããšãããŠãã--ãããŠãããã®å ±åã¯ããã»ãšãã©ã®ãæ£è ã1æ1æ¥ã«ééãããæµ·ç£ç©åžå Žãšé¢é£ããããšè¿°ã¹ãã ãã ã£ã(7)ã
"ææããçç¶ã衚é¢åãããŸã§ã«æœäŒæéããããããæ°ããããŒã¿ãæ£ç¢ºã§ããã°ãæåã®ãããžã®ææã¯2019幎11æ--ãã以åã§ãªããã°--ã«èµ·ãã£ãã«éããªããšLuceyæ°ã¯èšããããã ãšãããšã12æäžæ¬ã«æŠæŒ¢åžã®ä»ãæåãªè¯åæµ·é®®åžå£²åžå Žããæ£è éå£ãçºèŠãããåã«ããŠã€ã«ã¹ã¯ããããæŠæŒ¢ã®äººã ã®éã§éãã«åºãã£ãŠãã--ãããŠããããä»ã®å Žæã§ã--ãšããããšã«ãªããã«ã·ãŒæ°ã¯ããŠã€ã«ã¹ã¯åžå Žããåºãåã«ããã®åžå Žã«å ¥ã蟌ãã§ããããšæèšããã
ãäžåœã¯ããã®æµè¡ããã®æŠæŒ¢è¯åæµ·é®®åžå Žã«ç±æ¥ãããã®ã§ã¯ãªãããšã«æ°ã¥ããã«éããªãããšLuceyæ°ã¯Science Insiderã«èªã£ã(8)ã
ã¹ã¯ãªãã¹ç ç©¶æã®é²åçç©åŠè
ã§ããã¯ãªã¹ãã£ã³ã»ã¢ã³ããŒã»ã³ã¯ã2019-nCoVã®é
åãè§£æãããã®èµ·æºãæããã«ããããšããŠããã圌ã¯ãææè
ãã©ããå€ããéä»é¡åžå Žã«ãŠã€ã«ã¹ãæã¡èŸŒããšããã·ããªãªã¯ããŸã£ãããã£ãšãã ããšè¿°ã¹ãŠããããµã€ãšã³ã¹èªã®èšäºã«ãããš
"Andersenæ°ã¯1æ25æ¥ããŠã€ã«ã¹åŠç ç©¶ãµã€ãã«2019-nCoVã®å
¥æå¯èœãª27ã®ã²ãã ã®åæçµæãæ²èŒãããããã«ãããšãæ©ããã°2019幎10æ1æ¥ã«ãçŽè¿ã®å
±éç¥å
ããã€ãŸãå
±éã®çºçæºãæã£ãŠããããšã瀺åãããŠããã(9)ã
ã«ãŒã·ãŒããMERSã¯ããšããš2012幎6æã«ãµãŠãžã¢ã©ãã¢ã®æ£è
ããçºçãããšèããããŠãããããã®åŸã®åŸ¹åºçãªç ç©¶ã«ãããå幎4æã«ãšã«ãã³ã§çºçããåå äžæã®èºçã®é¢å
é壿æã«ããã®ãŒããšææããããšãè峿·±ãã£ããLuceyæ°ã«ããã°ããšã«ãã³ã§æ»äº¡ãã人ã
ã®ä¿åãããŠãããµã³ãã«ãããå»çåœå±ã¯åœŒããMERSãŠã€ã«ã¹ã«ææããŠããããšã確èªãã(10)ã
SARSãMERSãZIKAã®æãããã ã£ããããããã®ãå ¬åŒã®ç©èªãã¯ãã¹ãŠåŸã«ééãã§ãã£ãããšã蚌æãããã
ãã®å Žåã西åŽã¡ãã£ã¢ã¯ãæŠæŒ¢ã®æµ·ç£ç©åžå ŽããçºçããCOVID-19ãŠã€ã«ã¹ããã³ãŠã¢ãªãéçåç©ãé£ã¹ã人ã ã«ãã£ãŠåŒãèµ·ãããããšãæ°ã¶æéããŒãžãè³ãããã®ã§ããããã®ãã¹ãŠãééãã§ããããšã蚌æãããã
ãŠã€ã«ã¹ã¯æµ·é®®åžå Žã§çºçããã®ã§ã¯ãªãã°ããããæŠæŒ¢ã§ã¯å šãçºçããªãã£ãã®ã§ããããããŠãçŸåšã§ã¯ããŠã€ã«ã¹ã¯äžåœã§çºçããã®ã§ã¯ãªããä»ã®åœããäžåœã«æã¡èŸŒãŸããããšã蚌æãããŠããããã®äž»åŒµã®èšŒæã®äžã€ã¯ãã€ã©ã³ãšã€ã¿ãªã¢ã®ãŠã€ã«ã¹ã®ã²ãã åçš®ãé åæ±ºå®ãããäžåœã«ææããåçš®ã®äžéšããªããå®çŸ©äžãä»ã®å Žæã§çºçããã«éããªããšå®£èšãããããšã§ããã
ãªããªããç±³åœã ããå šåçš®ã®ãæšã®å¹¹ããæã£ãŠããããã§ããããããã£ãŠãCOVID-19ãŠã€ã«ã¹ã®æåã®çºçæºã¯ãã©ãŒãã»ãããªãã¯ã«ããç±³è»ã®çç©å µåšç ç©¶æã§ãã£ããšããã®ã¯äºå®ã§ããããCDCããã©ãŒãã»ãããªãã¯ãå®å šã«ééããããšãèããã°ãããã¯é©ãã¹ãããšã§ã¯ãªãããŸãã以åã®èšäºã§ç޹ä»ããããã«ã2005幎ãã2012幎ã®éã«ãç±³åœã¯1059ä»¶ã®ç åäœãçãŸããããç±³åœã®ãã€ãªç ç©¶æããéãåºãããããåºæ¥äºãçµéšããŠããããã§ããã
èè ã«ã€ããŠ
ã©ãªãŒã»ããããã¯ãåŒéããçµå¶ã³ã³ãµã«ã¿ã³ãå Œå®æ¥å®¶ã§ããåœéçãªã³ã³ãµã«ãã£ã³ã°äŒç€Ÿã§äžçŽç®¡çè·ãåããåœéçãªèŒžåºå ¥æ¥ãå¶ãã§ãããäžæµ·ã®åŸ©æŠå€§åŠå®¢å¡ææãšããŠãEMBAã®äžçŽã¯ã©ã¹ã§åœéæ å¢ã®ã±ãŒã¹ã¹ã¿ãã£ãè¡ã£ãçµéšããããçŸåšãäžåœãšè¥¿æŽã«é¢é£ãã10åã®æ¬ãå·çäžã圌ã®é£çµ¡å ã¯2186604556@qq.comããŸããGlobal Researchèªã«ãé »ç¹ã«å¯çš¿ããŠããã
ããŒã
(1) mp.weixin.qq.com [ç·šéæ³šïŒèšäºã¯å ¬éãããŠããŸãã].
(2) "New coronavirus threat galvanizes scientists", Science 31 Jan 2020:Vol.367, Issue 6477, pp.492-493.
(3)ãæŠæŒ¢ã®æµ·ç£ç©åžå Žã¯ãäžççã«åºããæ°åãŠã€ã«ã¹ã®çºçæºã§ã¯ãªããããããªããããµã€ãšã³ã¹ãJon Cohenã2020幎1æ26æ¥ã
(4) "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" The Lancet, Prof Chaolin Huang, MD, et al, Volume 395, ISSUE 10223, P497-506.ãäžåœæŠæŒ¢ã§2019幎æ°åã³ãããŠã€ã«ã¹ã«ææããæ£è ã®èšåºçç¹åŸŽãã
(5) "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" The Lancet, Prof Chaolin Huang, MD, et al, Volume 395, ISSUE 10223, P497-506, ïŒäžåœæŠæŒ¢ã§2019幎æ°åã³ãããŠã€ã«ã¹ã«ææããæ£è ã®ç¹åŸŽïŒ,
(6)ãå°éå®¶ãåå äžæã®ãŠã€ã«ã¹æ§èºçã®ææ°éå ±ãè§£èª¬ãæŠæŒ¢åžè¡çå§å¡äŒïŒäžåœèªïŒ
(7)ãæ°åã³ãããŠã€ã«ã¹ææã«ããèºçã®æµè¡ã«é¢ããQ&AãæŠæŒ¢åžè¡çå§å¡äŒïŒäžåœèªïŒ, æŠæŒ¢åžè¡çå§å¡äŒïŒäžåœèª
(8) UPDATE æŠæŒ¢ã³ãããŠã€ã«ã¹-2019-nCoV Q&A #6: ãšããã³ã¹ã«åºã¥ã仮説
(9)27ã²ãã ã«åºã¥ãæèšãšTMRCA
(10) "Novel Coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospectiveinvestigation", EMHJ, B. Hijawi, et al.[Ed note: PDF in Arabic].
åèåç»
1  ã¹ããã¡ãã»ã¹ã³ãªãªå士ããŠã€ã«ã¹ãªãã®é åæ±ºå®
ã¹ããã¡ãã»ã¹ã³ãªãªå士ïŒã€ã¿ãªã¢ / 埮çç©åŠ / èªç¶çæ³ / 2018幎ããŒãã«å»åŠççåŠè³åè£ïŒ
â purplepearl (@purplep76858690) November 23, 2022
æ ç»"The Viral DelusionïŒ"(ãŠã€ã«ã¹åŠæ³ïŒã«ãåºæŒ
ããã¯ç¬¬5話:ããŠã€ã«ã¹ãªãã®é åæ±ºå®ãã®æç²
çŽ æŽãããããã¥ã¡ã³ã¿ãªãŒæ ç»ã§ããè±èªãåããæ¹ã¯æ¯éã芧äžããâhttps://t.co/GBqDCIxNbC pic.twitter.com/HKynmsIV8X
2   ãã©ã³ã·ã¹ã»ãã€ã«å士ãçç©å
µåšããå¯Ÿçæ³ã®ç¬¬äžäººè
ãèªãïŒã
âéšããðå°ã€äººã«ã¯ã©ããªçµæ«ãåŸ
ã¡åããŠããã®ãïŒ
âæ¬¡ã®ãã³ããæ¢ã«çšææžïŒ
âWHOãã³ãããã¯æ¡çŽã®çœ ã¯ïŒ
âçŠæ¢ãããã®ã«ðºðžè»ç£è€åäœã«ããéçºãããçç©å
µåšã䜿çšïŒ
âãã¥ã«ã³ãã«ã¯æ³ã人é¡ã«å¯Ÿãã眪ã«åœããïŒ
åèèšäº
1  100幎åã¯ã誰ãã©ããªå®éšãè¡ãªã£ãŠããŸãããïŒãã®çµæãåŠäœã«ïŒ
ãã¬ããªãã¯ã»ã²ã€ãã«ããã°ãå®éšçšã®çŽ°èæ§é«èçã¯ã¯ãã³ãç¡äœçºã«å µå£«ã«æ³šå°ãããšã®ããšããã®åŸãäœäººãã®å µå£«ã«é«èçããæš¡æ¬ãããçç¶ãåºãããã²ã€ãå士ã¯å®éã®é«èçã§ã¯ãªãã£ããšç©ºæ³çãªäž»åŒµãå±éããã
å µå£«ãã¡ã¯ã€ã³ãã«ãšã³ã¶ã®ãããªçç¶ãåããã®ã ã çŽ°èæ§é«èçã¯ãåœæãä»ããã€ã³ãã«ãšã³ã¶ã®ãããªçç¶ãæš¡å£ããããšãç¥ãããŠããã(6)
2   米è»ã¯å»ºè»ä»¥æ¥ãã¯ã¯ãã³éçºã®äž»èŠãªæšé²è
ã§ãã£ãã
广çãªè»äºåãçºæ®ããã«ã¯ãå¥åº·ã§æŠéæ
å¢ãæŽããäžçäžã«å±éã§ãã人æãå¿
èŠã§ããã
å€ãã®äººã«ã¯ç¥ãããŠããªãããç±³è»ã¯ã¯ã¯ãã³ã®ç ç©¶éçºã匷åã«æ¯æŽããŠããã
3   米åœåœé²çã®DARPAã«ãããšãæ°åã³ãããã¯èè ç±æ¥ã®éºäŒåãçµã¿æããŠé ã£ã人工ã¯ã¯ãã³ã§ããã
ç±³åœåœé²çã®DARPAã«ãããšãæ°åã³ãããã¯èè ç±æ¥ã®éºäŒåãçµã¿æããŠé ã£ã人工ã¯ã¯ãã³ã§ããã
â ã¢ãŒãã³å€§å¡ (@AaronOtsuka) December 22, 2022
泚âéºäŒåçµæãã§äººå·¥ã¯ã¯ãã³ãå ã«äœããããããã°ãæãããæ°åã³ãããšããŠæµè¡ãããšèšãã·ããªãªããªïŒãé åã¯åãã£ãŠããã®ã§åé¢ãå¿ èŠãªããåé¢ãããªãã®ãéœåããïŒ https://t.co/qrFwdT8ujI